Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra
- 12 January 2001
- journal article
- Published by Elsevier in Brain Research
- Vol. 888 (2) , 336-342
- https://doi.org/10.1016/s0006-8993(00)03087-0
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseasesProgress in Neurobiology, 2000
- The nicotinic acetylcholine receptor agonist (±)-epibatidine increases FGF-2 mRNA and protein levels in the rat brainMolecular Brain Research, 1999
- Nicotine blocks TNF-?-mediated neuroprotection to NMDA by an ?-bungarotoxin-sensitive pathwayJournal of Neurobiology, 1998
- Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the ratNeuroscience, 1998
- Chronic continuous infusion of (−)nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned ratNeuroscience, 1996
- Efficacy of Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 on Neurochemical and Behavioral Deficits Associated with Partial Nigrostriatal Dopamine LesionsJournal of Neurochemistry, 1994
- Nicotine-induced protection of cultured cortical neurons againstN-methyl-D-aspartate receptor-mediated glutamate cytotoxicityBrain Research, 1994
- Nicotine Enhances 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine NeurotoxicityJournal of Neurochemistry, 1992
- Time Course of Adaptations in Dopamine Biosynthesis, Metabolism, and Release Following Nigrostriatal Lesions: Implications for Behavioral Recovery from Brain InjuryJournal of Neurochemistry, 1987
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973